Sphingomyelin Potentiates Chemotherapy of Human Cancer Xenografts
Authors:
- David E. ModrakDMDavid E. Modrak
- Walter LewWLWalter Lew
- David M. GoldenbergDGDavid M. Goldenberg
- Rosalyn BlumenthalRBRosalyn Blumenthal
- 1 February 2000
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 268 (2) , 603-606
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Expression of Glucosylceramide Synthase, Converting Ceramide to Glucosylceramide, Confers Adriamycin Resistance in Human Breast Cancer CellsJournal of Biological Chemistry, 1999
- Signal transduction of stress via ceramideBiochemical Journal, 1998
- REGULATION OF CERAMIDE PRODUCTION AND APOPTOSISAnnual Review of Physiology, 1998
- Sphingomyelinases in cell regulationSeminars in Cell & Developmental Biology, 1997
- Sequential Operation of Ceramide Synthesis and ICE Cascade in CPT-11-Initiated Apoptotic Death SignalingExperimental Cell Research, 1997
- Agents that Reverse Multidrug Resistance, Tamoxifen, Verapamil, and Cyclosporin A, Block Glycosphingolipid Metabolism by Inhibiting Ceramide Glycosylation in Human Cancer CellsJournal of Biological Chemistry, 1997
- Acid Sphingomyelinase–Deficient Human Lymphoblasts and Mice Are Defective in Radiation-Induced ApoptosisCell, 1996
- Isolation and characterisation of Kasumi-1 human myeloid leukaemia cell line resistant to tumour necrosis factor alpha-induced apoptosisBritish Journal of Cancer, 1996
- Tumor cell resistance to apoptosis due to a defect in the activation of sphingomyelinase and the 24 kDa apoptotic protease (AP24)The FASEB Journal, 1996
- Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signalsCell, 1995